During the past decade, The First Affiliated Hospital of Fujian Medical University conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 7 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 5 clinical trials were completed. i.e. 6.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Affiliated Hospital of Fujian Medical University" #1 sponsor was "First Affiliated Hospital of Fujian Medical University" with 8 trials, followed by "BeiGene" with 6 trials sponsored, "Pfizer" with 6 trials sponsored, "Reistone Biopharma Company Limited" with 6 trials sponsored and "Nanfang Hospital of Southern Medical University" with 6 trials sponsored. Other sponsors include 98 different institutions and companies that sponsored additional 79 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Affiliated Hospital of Fujian Medical University" #1 collaborator was "First Affiliated Hospital of Fujian Medical University" with 7 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Huazhong University of Science and Technology" with 3 trials as a collaborator, "Nanfang Hospital of Southern Medical University" with 3 trials as a collaborator and "Ruijin Hospital" with 3 trials as a collaborator. Other collaborators include 240 different institutions and companies that were collaborators in the rest 232 trials.

According to Clinical.Site data, the most researched conditions in "The First Affiliated Hospital of Fujian Medical University" are "Chronic Hepatitis B" (4 trials), "Hepatitis B, Chronic" (4 trials), "Atopic Dermatitis" (3 trials), "Erectile Dysfunction" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "The First Affiliated Hospital of Fujian Medical University" in a lesser frequency.

Most popular intervention types in "The First Affiliated Hospital of Fujian Medical University" are "Drug" (94 trials), "Device" (15 trials), "Procedure" (9 trials), "Other" (8 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Tislelizumab" (7 trials), "Cisplatin" (4 trials), "placebo" (4 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "The First Affiliated Hospital of Fujian Medical University" are 124 trials for "All" genders, 7 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "The First Affiliated Hospital of Fujian Medical University". 2 are not yet recruiting, 50 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in The First Affiliated Hospital of Fujian Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The First Affiliated Hospital of Fujian Medical University, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 21 trials that are defined as “Not Applicable".